E-Paper
US to okay female Viagra
A panel of the United States' Food and Drug Administration will soon wrestle with a question that has bedeviled poets, philosophers and generations of frustrated men: What do women want?
A panel of federal advisers will soon wrestle with a question that has bedeviled poets, philosophers and generations of frustrated men: What do women want?
That enigma will be part of a Food and Drug Administration committee's deliberations on June 18 when it considers endorsing the first pill designed to do for women what Viagra did for men: boost their sex lives.
A German pharmaceutical giant wants to sell a drug with the unsexy name "flibanserin".
The prospect of the drug's approval has triggered debate over whether the medication represents a long-sought step toward equity for women's health or the latest example of the pharmaceutical industry fabricating a questionable disorder to sell unnecessary drugs.
"Achieving a happy and healthy sex life can be a real and important problem for some women," said Amy Allina of the National Women's Health Network.
"But we have lots of questions about the pink Viagra."
In exclusive partnership with The Washington Post. For additional content please visit www. washingtonpost.com
